dan 2163 has been researched along with sch 23390 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiranita, T; Nawata, Y; Yamamoto, T | 1 |
| Gerlai, R; Muraleetharan, A; Nowicki, M; Tran, S | 1 |
2 other study(ies) available for dan 2163 and sch 23390
| Article | Year |
|---|---|
A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Topics: Adrenergic Agents; Amisulpride; Amphetamine-Related Disorders; Animals; Benzazepines; Benzofurans; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Wistar; Self Administration; Sulpiride | 2010 |
Differential effects of dopamine D1 and D 2/3 receptor antagonism on motor responses.
Topics: Amisulpride; Animals; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Zebrafish | 2015 |